| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/02/2005 | WO2004066947B1 Hyperthermia oncolysis co-therapy |
| 06/02/2005 | WO2004037182A3 Active specific immunotherapy of cancer metastasis |
| 06/02/2005 | US20050120399 Reconstructing mammalian embryos by transfer of a donor nucleus to enucleated oocyte or one cell zygote for production of genetically identical individuals; uniformity of meat products and animal management |
| 06/02/2005 | US20050119472 GB virus C and methods of treating viral infections |
| 06/02/2005 | US20050119223 Injectable solution containing a shark-derived chondroitin sulfate iron colloid |
| 06/02/2005 | US20050119210 Using genes encoding transmembrane protein as markers; targets for cancer therapy; drug screening |
| 06/02/2005 | US20050118715 Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
| 06/02/2005 | US20050118694 Culturing microorganism under aerobic conditions and generating preferential biopolymer particle; nutraceuticals; vitamins |
| 06/02/2005 | US20050118655 Using helminth mixture as therapeutic tool in treatment of autoimmune and allergic disorders; antihelmintics |
| 06/02/2005 | US20050118567 Method for determining sensitivity to a bacteriophage |
| 06/02/2005 | US20050118277 Protective factors against inflammation, burns and noxious stimuli |
| 06/02/2005 | US20050118274 cells are combined into capsule units by means of an enveloping substance which surrounds the cells; order to prevent coagulation or rejection, coagulation-inhibiting agents or coagulation-preventing structures are placed in or on the enveloping substance; liver bioreactor |
| 06/02/2005 | US20050118196 Novel therapeutic processes for establishing or enhancing an immunized state, and compositions useful therefor |
| 06/02/2005 | US20050118195 Virus causing respiratory tract illness in susceptible mammals |
| 06/02/2005 | US20050118192 Viral preparations, vectors, immunogens, and vaccines |
| 06/02/2005 | US20050118173 Compositions and methods to accelerate hematologic recovery |
| 06/02/2005 | US20050118170 Use of discoidin domain receptor 1 (ddr1) and agents that affect the ddr1/collagen pathway |
| 06/02/2005 | US20050118150 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine |
| 06/02/2005 | US20050118148 Compositions and methods related to mammalian Maf-A |
| 06/02/2005 | US20050118147 Cotransplanting stem cells from multiple stem cell sources such as bone marrow, peripheral blood, or umbilical cord blood; suppressing graft versus host disease |
| 06/02/2005 | US20050118146 In vitro synthesis of a layered cell sorted tissue |
| 06/02/2005 | US20050118142 Stem cells are from a syngeneic, allogeneic or xenogeneic donor; the composition of donor CD34+ hematopoietic cells in combination with donor alpha beta TCR+ T-cells reduces the risk of Graft Versus Host Disease by half |
| 06/02/2005 | US20050118117 Methods for identifying risk of melanoma and treatments thereof |
| 06/02/2005 | CA2545912A1 Autologous treatment of degenerated disc with cells |
| 06/02/2005 | CA2545198A1 Skeletal muscle-derived cells and methods related thereto |
| 06/02/2005 | CA2545049A1 Method for proliferating cardiomyocytes |
| 06/02/2005 | CA2544734A1 Fluid composition for increased total water intake |
| 06/02/2005 | CA2543072A1 Compositions comprising melittin-derived peptides and methods for the potentiation of immune responses against target antigens |
| 06/02/2005 | CA2515890A1 Novel insertion sites in pox vectors |
| 06/01/2005 | EP1535994A1 Human bone stem cells |
| 06/01/2005 | EP1535993A1 Biomolecule transfer method using virus envelope and composition and system therefor |
| 06/01/2005 | EP1535626A2 Actinomyces pyogenes and actinomyces pyogenes/fusobacterium necrophorum vaccines for immunizing cattle and sheep |
| 06/01/2005 | EP1534847A1 Retroviral vector and stable packaging cell lines |
| 06/01/2005 | EP1534822A1 Immunotherapy using modulators of notch signalling |
| 06/01/2005 | EP1534820A2 Ex-vivo expansion of hematopoietic stem cell populations in mononuclear cell cultures |
| 06/01/2005 | EP1534819A2 Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase |
| 06/01/2005 | EP1534807A1 A process for decreasing the amount of cholesterol in a marine oil using a volatile working fluid |
| 06/01/2005 | EP1534345A2 Method and device for inducing biological processes by micro-organs |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534261A2 Epa and dha enriched omega-3 supplement for the treatment of dry eye, meibomianitis and xerostomia |
| 06/01/2005 | EP1534243A1 Treating alzheimers using delipidated protein particles |
| 06/01/2005 | EP1435779A4 Modulation of stem cells using zinc finger proteins |
| 06/01/2005 | EP1143927B1 Facial tissue composition and method of use for sequestration of nasal secretion skin irritants |
| 06/01/2005 | EP1100878B1 Process for producing genetically modified cd34-negative adherently growing haematopoietic stem cells |
| 06/01/2005 | EP0981353B1 Facilitation of repair of neural injury with cm101/gbs toxin |
| 06/01/2005 | CN1622836A Scaffolds for tissue engineered hair |
| 06/01/2005 | CN1622826A Stimulation of bone growth and cartilage formation with thrombing peptide derivatives |
| 06/01/2005 | CN1622823A Purification of red blood cells by separation and infiltration |
| 06/01/2005 | CN1622816A Composition and method for augmenting kidney function |
| 06/01/2005 | CN1622815A Method |
| 06/01/2005 | CN1622801A Method and device for feeding living cells into a biological body fluid |
| 06/01/2005 | CN1621045A Externally applied liniment containing propolis |
| 06/01/2005 | CN1620936A Nutritious and health oral liquid and jelly of donkey-hide gelatin |
| 06/01/2005 | CN1620931A Donkey-hide gelatin nutritious and healthcare capsule |
| 06/01/2005 | CN1203900C Methods for quenching pathogen inactivators in biological materials |
| 06/01/2005 | CN1203888C Medicine for treating various fungal skin disease or bromidrosis |
| 06/01/2005 | CN1203884C Medicament for treating rheumatism |
| 06/01/2005 | CN1203883C Medicine for treating liver cirrhosis |
| 06/01/2005 | CN1203882C Medicinal composition for treating wound surface |
| 06/01/2005 | CN1203880C Chinese patent medicine for treating hypotension and preparing method thereof |
| 06/01/2005 | CN1203871C Medicine for treating diseases of digestive system |
| 06/01/2005 | CN1203870C Medicament for treating chronic bronchitis and bronchial asthma and preparation method thereof |
| 06/01/2005 | CN1203869C Technique for preparing granules of toad oil |
| 06/01/2005 | CN1203868C External-use disinfecting medicinal preparation for women |
| 06/01/2005 | CN1203867C Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia |
| 05/31/2005 | US6900302 Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group B streptococcal carbohydrates |
| 05/31/2005 | US6900195 Administering to a subject an effective amount of a manzamine, manzamine derivative or analog or isomer to treat bacterial, parasitic, viral and other infections |
| 05/31/2005 | US6900174 Comprises mineral (chromium and/or vanadium) bound by glycoprotein matrix produced by yeast (Saccharomyces cervisiae); for inhibiting absorption of dietary starch; for obesity and other carbohydrate limited dieting |
| 05/31/2005 | US6900055 Oxygen permeable biocompatible elastomer for propagating viable tissue; tissue engineering |
| 05/31/2005 | US6900054 Propagating preferential oligodendrocytes and/or astrocytes using embryonic neural cell adhesion molecule (E-NCAM) differentiated stem cells for treating neurological or neurodegenerative disease |
| 05/31/2005 | US6900051 Generating insulin secreting cells; obtain mammalian pancreatic tissues, dissociate cells, dedifferentiate into insulin precursor cells, isolate and propagate cells |
| 05/31/2005 | US6900049 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/31/2005 | US6900038 eNOS mutations useful for gene therapy and therapeutic screening |
| 05/31/2005 | US6900035 Comprises human papilloma virus (HPV) fusion between mycobacterial chaperone protein and viral E6 protein for use in treating tumors |
| 05/31/2005 | US6899873 Porous, biodegradable polymer; tissue culture |
| 05/31/2005 | US6899872 Absorbable dietary composition for improving the biological balance of intestinal tract flora |
| 05/31/2005 | US6899863 Method for preparing membrane vesicles |
| 05/31/2005 | US6899294 Hatchery eggshell waste processing method and device |
| 05/31/2005 | CA2267157C Cancer immunotherapy using tumor cells combined with mixed lymphocytes |
| 05/31/2005 | CA2137595C Treating hormone-dependent conditions |
| 05/26/2005 | WO2005047496A1 Cell culture method, three-dimensional cell culture method, three-dimensional tissue, artificial organ and tissue transplantation method |
| 05/26/2005 | WO2005047495A1 Implantable neuronal networks |
| 05/26/2005 | WO2005047494A2 Haematopoietic stem cells suitable for transplantation, their preparation and pharmaceutical compositions comprising them |
| 05/26/2005 | WO2005047492A1 Melanocytes in therapy of neurodegenerative diseases |
| 05/26/2005 | WO2005047491A2 Methods of using g-csf mobilized c-kit+cells in the production of embryoid body-like cell clusters for tissue repair and in the treatment of cardiac myopathy |
| 05/26/2005 | WO2005047473A2 Single vector dual gene therapy for pulmonary hypertension |
| 05/26/2005 | WO2005047458A2 Modified recombinant vaccina viruses and other microorganisms, uses thereof |
| 05/26/2005 | WO2005046748A1 Device and method for attracting diseased cells and foreign substances |
| 05/26/2005 | WO2005046705A1 Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values |
| 05/26/2005 | WO2005046703A1 Use of strain of bacillus and byproducts thereof for inhibiting formation of blood vessels |
| 05/26/2005 | WO2005046587A2 Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use |
| 05/26/2005 | WO2005046579A2 Defined dose therapeutic phage |
| 05/26/2005 | WO2005046560A2 Glans compatible single unit semen collection and storage device, kit and related methods of use |
| 05/26/2005 | WO2005046454A2 Methods of using gelsolin to treat or prevent bacterial sepsis |
| 05/26/2005 | WO2005046445A2 Artificial tissue systems and uses thereof |
| 05/26/2005 | WO2005046327A1 A novel long-term three dimensional culture system |
| 05/26/2005 | WO2004083392A3 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 05/26/2005 | WO2003004039A9 Composition comprising soy and use thereof in the prevention and/or treatment of various diseases |
| 05/26/2005 | US20050113291 Use of a substance which binds to and initiates signaling of the human SARP-1 receptor or a substance which stimulates release or potentiates the activity of endogenous SARP-1 for the manufacture of a medicament for the treatment and/or prevention of scleroderma, in particular of systemic sclerosis |
| 05/26/2005 | US20050112762 Cell differentiation; cell proliferation; immunotherapy of cancer; infectons; autoimmune diseases |